The Administrative Panel on Biosafety (APB) is an established institutional biosafety committee that reviews projects involving infectious agents, recombinant DNA (rDNA), and synthetic nucleic acid molecules (sNA).
APB approval is required for any work using:
- Biological agents classified as Biosafety Level 2 (BSL-2) or above
- rDNA classified as non-exempt by the National Institutes of Health (NIH)
To determine if your research requires APB approval, see the NIH rDNA Guidelines, Safety Data Sheets (MSDS) for Infectious Substances, and CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL), 5th Edition. You can also contact our Biosafety division and review the summary of the NIH rDNA Guidelines.
The APB uses the eProtocol Biosafety application process, a web-based system that coordinates new protocols, updates, renewals, and reminders.